Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure

This study has been terminated.

( Preliminary analysis of 11 patients did not demonstrate the efficacy required. )

Study NCT00414869 Information provided by Axcan Pharma

First Received: December 21, 2006 Last Updated: October 31, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2007
Primary Completion Date:	February 2007 (Final data collection date for primary outcome measure)